Cargando…

A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study

OBJECTIVE: To present the surgical outcomes of advanced epithelial ovarian cancer (AEOC) since the implementation of a personalized approach and to validate multiple predictive models for R0 resection. METHODS: Personalized strategies included: 1) Non-invasive model: preoperative clinico-radiologica...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Zheng, Wen, Hao, Jiang, Zhaoxia, Liu, Shuai, Ju, Xingzhu, Chen, Xiaojun, Xia, Lingfang, Xu, Junyan, Bi, Rui, Wu, Xiaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078898/
https://www.ncbi.nlm.nih.gov/pubmed/30022629
http://dx.doi.org/10.3802/jgo.2018.29.e65
_version_ 1783345163921260544
author Feng, Zheng
Wen, Hao
Jiang, Zhaoxia
Liu, Shuai
Ju, Xingzhu
Chen, Xiaojun
Xia, Lingfang
Xu, Junyan
Bi, Rui
Wu, Xiaohua
author_facet Feng, Zheng
Wen, Hao
Jiang, Zhaoxia
Liu, Shuai
Ju, Xingzhu
Chen, Xiaojun
Xia, Lingfang
Xu, Junyan
Bi, Rui
Wu, Xiaohua
author_sort Feng, Zheng
collection PubMed
description OBJECTIVE: To present the surgical outcomes of advanced epithelial ovarian cancer (AEOC) since the implementation of a personalized approach and to validate multiple predictive models for R0 resection. METHODS: Personalized strategies included: 1) Non-invasive model: preoperative clinico-radiological assessment according to Suidan criteria with a predictive score for all individuals. Patients with a score 0–2 were recommended for primary debulking surgery (PDS, group A), or otherwise were counseled on the choices of PDS, neoadjuvant chemotherapy (NAC, group B) or staging laparoscopy (S-LPS). 2) Minimally invasive model: S-LPS with a predictive index value (PIV) according to Fagotti. Individuals with a PIV <8 underwent PDS (group C) or otherwise received NAC (group D). Intraoperative assessment (with Eisenkop, peritoneal cancer index [PCI], and Aletti scores) and surgical results were prospectively collected. RESULTS: Between September 2015 and August 2017, 161 pathologically confirmed epithelial ovarian cancer patients were included. A total of 52 (32.3%) patients had a predictive score of 0–2, and 109 (67.7%) patients had a score ≥3. Among these individuals, 41 (25.5%) patients received S-LPS. Finally, 110 (68.3%) patients underwent PDS (A+C), and 51 (31.7%) patients received NAC (B+D). The R0 resection rates in PDS and NAC patients were 56.4% and 60.8%, respectively. The area under the curve (AUC) of Suidan criteria was 0.548 for group (A+C). The AUC of Fagotti score was 0.702 for group C. The AUC of Eisenkop, PCI, and Aletti scores were 0.808, 0.797, and 0.524, respectively. CONCLUSION: The Suidan criteria were not effective in these AEOC patients. S-LPS was helpful in decision-making for PDS and should be endorsed in the future.
format Online
Article
Text
id pubmed-6078898
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
record_format MEDLINE/PubMed
spelling pubmed-60788982018-09-01 A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study Feng, Zheng Wen, Hao Jiang, Zhaoxia Liu, Shuai Ju, Xingzhu Chen, Xiaojun Xia, Lingfang Xu, Junyan Bi, Rui Wu, Xiaohua J Gynecol Oncol Original Article OBJECTIVE: To present the surgical outcomes of advanced epithelial ovarian cancer (AEOC) since the implementation of a personalized approach and to validate multiple predictive models for R0 resection. METHODS: Personalized strategies included: 1) Non-invasive model: preoperative clinico-radiological assessment according to Suidan criteria with a predictive score for all individuals. Patients with a score 0–2 were recommended for primary debulking surgery (PDS, group A), or otherwise were counseled on the choices of PDS, neoadjuvant chemotherapy (NAC, group B) or staging laparoscopy (S-LPS). 2) Minimally invasive model: S-LPS with a predictive index value (PIV) according to Fagotti. Individuals with a PIV <8 underwent PDS (group C) or otherwise received NAC (group D). Intraoperative assessment (with Eisenkop, peritoneal cancer index [PCI], and Aletti scores) and surgical results were prospectively collected. RESULTS: Between September 2015 and August 2017, 161 pathologically confirmed epithelial ovarian cancer patients were included. A total of 52 (32.3%) patients had a predictive score of 0–2, and 109 (67.7%) patients had a score ≥3. Among these individuals, 41 (25.5%) patients received S-LPS. Finally, 110 (68.3%) patients underwent PDS (A+C), and 51 (31.7%) patients received NAC (B+D). The R0 resection rates in PDS and NAC patients were 56.4% and 60.8%, respectively. The area under the curve (AUC) of Suidan criteria was 0.548 for group (A+C). The AUC of Fagotti score was 0.702 for group C. The AUC of Eisenkop, PCI, and Aletti scores were 0.808, 0.797, and 0.524, respectively. CONCLUSION: The Suidan criteria were not effective in these AEOC patients. S-LPS was helpful in decision-making for PDS and should be endorsed in the future. Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018-09 2018-04-23 /pmc/articles/PMC6078898/ /pubmed/30022629 http://dx.doi.org/10.3802/jgo.2018.29.e65 Text en Copyright © 2018. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Feng, Zheng
Wen, Hao
Jiang, Zhaoxia
Liu, Shuai
Ju, Xingzhu
Chen, Xiaojun
Xia, Lingfang
Xu, Junyan
Bi, Rui
Wu, Xiaohua
A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study
title A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study
title_full A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study
title_fullStr A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study
title_full_unstemmed A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study
title_short A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study
title_sort triage strategy in advanced ovarian cancer management based on multiple predictive models for r0 resection: a prospective cohort study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078898/
https://www.ncbi.nlm.nih.gov/pubmed/30022629
http://dx.doi.org/10.3802/jgo.2018.29.e65
work_keys_str_mv AT fengzheng atriagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy
AT wenhao atriagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy
AT jiangzhaoxia atriagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy
AT liushuai atriagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy
AT juxingzhu atriagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy
AT chenxiaojun atriagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy
AT xialingfang atriagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy
AT xujunyan atriagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy
AT birui atriagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy
AT wuxiaohua atriagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy
AT fengzheng triagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy
AT wenhao triagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy
AT jiangzhaoxia triagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy
AT liushuai triagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy
AT juxingzhu triagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy
AT chenxiaojun triagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy
AT xialingfang triagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy
AT xujunyan triagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy
AT birui triagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy
AT wuxiaohua triagestrategyinadvancedovariancancermanagementbasedonmultiplepredictivemodelsforr0resectionaprospectivecohortstudy